News
Patent Expiry Drives Rs 50,000 Cr Generic Semaglutide Market
Pune, India | January 05, 2026 The expiry of the generic semaglutide patent is creating a massive opportunity for India’s pharmaceutical industry. Analysts predict this
Read More